Cardiorenal Syndrome: Molecular Pathways Linking Cardiovascular Dysfunction and Chronic Kidney Disease Progression
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26157440 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Fabian Vasquez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Nutrición y Dietética, Universidad Finis Terrae, Santiago 8320000, Chile. Hauptthemen laut MEDLINE: Cardio-Renal Syndrome, Renal Insufficiency, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiorenal syndrome (CRS) is a multifactorial clinical condition characterized by the bidirectional deterioration of cardiac and renal function, driven by mechanisms such as renin–angiotensin–aldosterone system (RAAS) overactivation, systemic inflammation, oxidative stress, endothelial dysfunction, and fibrosis. The aim of this narrative review is to explore the key molecular pathways involved in CRS and to highlight emerging therapeutic approaches, with a special emphasis on nutritional interventions. We examined recent evidence on the contribution of mitochondrial dysfunction, uremic toxins, and immune activation to CRS progression and assessed the role of dietary and micronutrient factors. Results indicate that a high dietary intake of sodium, phosphorus additives, and processed foods is associated with volume overload, vascular damage, and inflammation, whereas deficiencies in potassium, magnesium, and vitamin D correlate with worse clinical outcomes. Anti-inflammatory and antioxidant bioactives, such as omega-3 PUFAs, curcumin, and anthocyanins from maqui, demonstrate potential to modulate key CRS mechanisms, including the nuclear factor kappa B (NF-κB) pathway and the NLRP3 inflammasome. Gene therapy approaches targeting endothelial nitric oxide synthase (eNOS) and transforming growth factor-beta (TGF-β) signaling are also discussed. An integrative approach combining pharmacological RAAS modulation with personalized medical nutrition therapy and anti-inflammatory nutrients may offer a promising strategy to prevent or delay CRS progression and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Escuela de Nutrición y Dietética, Universidad Finis Terrae, Santiago 8320000, Chile.
- Escuela de Enfermería, Universidad Finis Terrae, Santiago 8320000, Chile.
- Escuela de Kinesiología, Facultad de Arte y Educación Física, Universidad Metropolitana en Ciencias de la Educación, Santiago 7760170, Chile.
- Unidad de Diálisis, Clínica Indisa, Santiago 7501014, Chile.
- Escuela de Medicina, Universidad de Chile, Santiago 8380492, Chile.
ORCID-Profile: Enrique Lorca-Ponce
Zitieren
APA
Vasquez, F., Tiscornia, C., Lorca-Ponce, E., Aicardi, V., & Vasquez, S. (2025). Cardiorenal Syndrome: Molecular Pathways Linking Cardiovascular Dysfunction and Chronic Kidney Disease Progression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157440
Vancouver
Vasquez F, Tiscornia C, Lorca-Ponce E, Aicardi V, Vasquez S. Cardiorenal Syndrome: Molecular Pathways Linking Cardiovascular Dysfunction and Chronic Kidney Disease Progression. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157440
BibTeX
@article{Vasquez2025,
author = {Vasquez, Fabian and Tiscornia, Caterina and Lorca-Ponce, Enrique and Aicardi, Valeria and Vasquez, Sofia},
title = {Cardiorenal Syndrome: Molecular Pathways Linking Cardiovascular Dysfunction and Chronic Kidney Disease Progression},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26157440}
}
EUVIMED